Key Highlights
- Streamlines medical record reviews for Life insurance, P&C insurance, and Legal industries.
- Reduces training and support costs while improving data integration and interoperability.
- Customizable platform with enhanced compliance, security, and innovative improvements.
- New ‘Chat’ module offers instant, accurate answers and click-to-evidence functionality.
- ‘Workflows’ module automates decision-making, saving time and enhancing efficiency.
Source: Business Wire
Notable Quotes
- “Our new platform is a testament to the incredible advancements in AI and machine learning that we have integrated into our solutions,” — Amit Man, CTO and Co-Founder at DigitalOwl
- “DigitalOwl’s Workflows is a game-changer for the insurance industry. The ability to assess severity, rather than merely noting the impairment, is transformative.” — Zach Pugh, Chief Underwriter and VP of Underwriting Transformation at Legal & General America
SoHC's Take
DigitalOwl’s all-in-one platform represents a significant leap forward in the field of medical record reviews. By leveraging cutting-edge technologies such as Generative AI and advanced Entity Recognition, the platform enhances accuracy and efficiency, setting a new standard for the insurance and legal industries. The introduction of innovative modules like ‘Chat’ and ‘Workflows’ further demonstrates DigitalOwl’s commitment to continuous improvement and customer-centric solutions. These advancements not only streamline workflows but also empower professionals to make more informed decisions, ultimately driving better business outcomes.
Related

Awell Secures $5m in Seed Funding: Revolutionizing Clinical Workflows
In the digital health landscape, Awell is making significant strides. With a recent seed funding boost, the company is set to redefine and streamline clinical workflows, enhancing patient care and healthcare operations. Key Highlights Funding Details: Awell secures a significant $5m, with Octopus Ventures at the helm.Platform's Promise: Awell aims to eliminate…

MedGenome Appoints Dr. Amit Kakar as Chairman of the Board
Key Highlights Dr. Amit Kakar appointed as Chairman of MedGenome Board. Succeeds Dr. Felix Olale, who now focuses on growing MedGenome’s US business. Dr. Kakar brings 30+ years of healthcare and life sciences experience. Previously held key leadership roles at Novo Holdings and GE Healthcare. MedGenome remains committed to global health and genomic innovation. Source: PR Newswire Notable Quotes…

ModMed Secures Majority Growth Investment from Clearlake Capital
Key Highlights Clearlake Capital has made a majority growth investment in ModMed® to fuel innovation and expansion.ModMed specializes in AI-powered medical practice solutions that improve clinical efficiency.The investment supports enhancements in AI, automation, and patient-provider workflows across multiple specialties.Clearlake aims to accelerate ModMed’s growth using its O.P.S.® framework for operational improvement.Warburg Pincus remains a strategic partner after supporting ModMed’s growth for eight…